Showing results (771-780 of 1,395) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|August 23, 2021
Utility of Homologous Recombination Deficiency Biomarkers Across Cancer TypesShiro Takamatsu, J B Brown, Ken Yamaguchi, et al.
JCO Precision Oncology|August 27, 2025
Therapeutic Outcomes and Biomarker Potential of CDKL3 of Neoadjuvant Chemotherapy in Patients With Stage IIIC Versus Stage IV Epithelial Ovarian CancerYing Jin, Ying Shan, Wen Guo, et al.
JCO Precision Oncology|August 27, 2025
PIK3CB Inhibitor GSK2636771 in Cancers With PTEN Mutation/Deletion or Loss of PTEN Protein Expression: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols N and PFilip Janku, Opeyemi A Jegede, Shannon L Puhalla, et al.
JCO Precision Oncology|October 26, 2019
Molecular Characterization and Clinical Outcomes of Primary Gleason Pattern 5 Prostate Cancer After Radical ProstatectomyPedro Isaacsson Velho, David Lim, Hao Wang, et al.
JCO Precision Oncology|September 2, 2025
Case-Control Study for 23 Cancer Types With Functional Analysis of CHEK2: Risk Estimation and Clinical Recommendations in East AsiaYuri Takehara, Yoshiaki Usui, Lenka Stolařová, et al.
JCO Precision Oncology|September 4, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk FactorsJoao V Alessi, James R Lindsay, Anita Giobbie-Hurder, et al.
JCO Precision Oncology|August 11, 2021
Making External Validation Valid for Molecular Classifier DevelopmentYilin Wu, Huei-Chung Huang, Li-Xuan Qin
JCO Precision Oncology|May 26, 2021
NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical OutcomeXiaonan Zhao, Chelsea Kotch, Elizabeth Fox, et al.
JCO Precision Oncology|May 26, 2021
Novel Approach Using Administrative Claims to Evaluate Trends in Oncology Multigene Panel Testing for Patients Enrolled in Medicare Advantage Health PlansEleanor O Caplan, William B Wong, Erin Ferries, et al.
JCO Precision Oncology|May 26, 2021
Unraveling Neuroendocrine Gallbladder Cancer: Comprehensive Clinicopathologic and Molecular CharacterizationTessa J J de Bitter, Leonie I Kroeze, Philip R de Reuver, et al.
Pageof 140